Renovaro Inc (RENB)
0.97
+0.05
(+5.75%)
USD |
NASDAQ |
May 17, 16:00
0.97
0.00 (0.00%)
After-Hours: 20:00
Renovaro Price: 0.97 for May 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 17, 2024 | 0.91 | 0.999 | 0.90 | 0.97 | 153448.0 |
May 16, 2024 | 0.98 | 1.169 | 0.82 | 0.9173 | 359562.0 |
May 15, 2024 | 1.13 | 1.13 | 0.90 | 0.9473 | 237061.0 |
May 14, 2024 | 1.16 | 1.169 | 1.01 | 1.04 | 258894.0 |
May 13, 2024 | 1.20 | 1.28 | 1.10 | 1.16 | 236060.0 |
May 10, 2024 | 1.19 | 1.26 | 1.13 | 1.13 | 189680.0 |
May 09, 2024 | 1.48 | 1.48 | 1.18 | 1.20 | 207357.0 |
May 08, 2024 | 1.46 | 1.550 | 1.32 | 1.46 | 269281.0 |
May 07, 2024 | 1.52 | 1.52 | 1.44 | 1.49 | 241583.0 |
May 06, 2024 | 1.48 | 1.55 | 1.48 | 1.48 | 177717.0 |
May 03, 2024 | 1.50 | 1.58 | 1.45 | 1.50 | 307481.0 |
May 02, 2024 | 1.50 | 1.58 | 1.42 | 1.49 | 217316.0 |
May 01, 2024 | 1.51 | 1.61 | 1.45 | 1.47 | 451282.0 |
Apr 30, 2024 | 1.54 | 1.84 | 1.50 | 1.58 | 1.006M |
Apr 29, 2024 | 1.50 | 1.62 | 1.24 | 1.56 | 439601.0 |
Apr 26, 2024 | 1.79 | 2.10 | 1.50 | 1.53 | 1.044M |
Apr 25, 2024 | 1.90 | 1.99 | 1.56 | 1.70 | 428027.0 |
Apr 24, 2024 | 1.89 | 2.09 | 1.89 | 1.97 | 206935.0 |
Apr 23, 2024 | 2.12 | 2.18 | 1.93 | 2.02 | 292628.0 |
Apr 22, 2024 | 2.160 | 2.20 | 2.11 | 2.15 | 110931.0 |
Apr 19, 2024 | 2.28 | 2.28 | 1.98 | 2.17 | 207913.0 |
Apr 18, 2024 | 2.25 | 2.38 | 2.13 | 2.30 | 127476.0 |
Apr 17, 2024 | 2.45 | 2.45 | 2.19 | 2.22 | 157146.0 |
Apr 16, 2024 | 2.55 | 2.70 | 2.34 | 2.42 | 200477.0 |
Apr 15, 2024 | 2.29 | 2.62 | 2.28 | 2.45 | 424130.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.40
Minimum
Jun 28 2023
12.55
Maximum
Nov 30 2021
3.936
Average
3.68
Median
Feb 14 2020
Price Benchmarks
DIH Holding US Inc | 1.64 |
AIM ImmunoTech Inc | 0.403 |
Perspective Therapeutics Inc | 1.60 |
Protalix BioTherapeutics Inc | 1.14 |
Armata Pharmaceuticals Inc | 2.59 |
Price Related Metrics
Price to Book Value | 0.8487 |
Earnings Yield | -80.41% |
Market Cap | 143.08M |